Abstract:Extracellular vesicles (EVs) mediate cellular communication by exchanging molecules such as proteins and nucleic acids. EVs are often generated in large quantities by cancer cells and are considered a promising diagnostic biomarker that may provide information on the tumor microenvironment. Tumor cells display characteristic metabolic changes such as the Warburg effect. However, many methods to characterize the metabolism of cells or EVs are destructive or indiscriminate, losing their individual heterogeneity. There is a need to better characterize the metabolism of individual breast cancer cells and single EVs to provide insights into their heterogeneous nature and interactions in the tumor microenvironment. Two-photon fluorescence lifetime imaging microscopy (FLIM), a label-free metabolic imaging technique that can spatially map the autofluorescence properties of NAD(P)H, was used to metabolically characterize breast cancer cells and their derived EVs. EVs of size 100-1000 nm were extracted via differential ultracentrifugation from media conditioned with breast cells. Metabolic stressors including various concentrations of glucose, pyruvate, and lactate were placed on human breast cancer (MDA-MB-231) cells in culture. Subsequently, cells and EVs were imaged with FLIM to determine the metabolic relationship between individual cells and EVs. Additionally, normal human breast cells (MCF10A) and breast cancer cells (MDA-MB-231, MCF7) were imaged with FLIM to determine the metabolic signatures of the three breast cell lines. Images were analyzed using a custom EV detection algorithm, FLIM-phasor analysis, and CellPose. EV collection was validated with Nanotracker Analysis, transmission electron microscopy, and Raman spectroscopy. Human MCF10A cell populations showed significantly lower mean lifetimes than either MDA-MB-231 or MCF7 cells. This suggests that FLIM can be used to differentiate populations of cancerous and non-cancerous breast cells in an individual, non-invasive manner. MDA-MB-231 EVs showed a Gaussian and heterogenous metabolic distribution of NAD(P)H fluorescence lifetimes. This suggests a range of different NAD(P)H species that are free and protein-bound. Fluorescence lifetimes from MDA-MB-231 EVs also demonstrated a wider standard deviation from their corresponding parent cells, and a different distribution from various sub-cellular regions of the parent cell. Additionally, when metabolites available in culture media were changed to induce metabolic changes in cells, similar metabolic changes were reflected in the signatures of their released EVs. These results indicate that FLIM can be a powerful label-free non-perturbative tool to examine both single cells and EVs, as well as their heterogeneous populations, in order to further understand the concurrent metabolic properties of breast cancer cells and their released EVs. Citation Format: Elisabeth M. Martin, Janet E. Sorrells, Edita Aksamitiene, Prabuddha Mukherjee, Aneesh Alex, Eric J. Chaney, Marina Marjanovic, Stephen A. Boppart. Metabolic characterization of breast cancer cells and extracellular vesicles using fluorescence lifetime imaging microscopy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 2466.

Label-free visualization and characterization of extracellular vesicles in breast cancer

Label-free Nonlinear Optical Signatures of Extracellular Vesicles in Liquid and Tissue Biopsies of Human Breast Cancer

Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detection

Abstract 2466: Metabolic characterization of breast cancer cells and extracellular vesicles using fluorescence lifetime imaging microscopy

Noninvasive Diagnosis and Molecular Phenotyping of Breast Cancer through Microbead-Assisted Flow Cytometry Detection of Tumor-Derived Extracellular Vesicles

Single Extracellular Vesicle Analysis Using Droplet Microfluidics.

Multiparametric profiling of HER2-enriched extracellular vesicles in breast cancer using Single Extracellular VEsicle Nanoscopy

Nanostructured‐Based optical readouts Interfaced with machine learning for identification of extracellular vesicles

Localized fluorescent imaging of multiple proteins on individual extracellular vesicles using rolling circle amplification for cancer diagnosis

Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer

Enabling Sensitive Phenotypic Profiling of Cancer-Derived Small Extracellular Vesicles Using Surface-Enhanced Raman Spectroscopy Nanotags

Defining the relationship between cellular and extracellular vesicle (EV) content in breast cancer via an integrative multi‐omic analysis

Dual Imaging Single Vesicle Surface Protein Profiling and Early Cancer Detection

Thermophoretic Glycan Profiling of Extracellular Vesicles for Triple-Negative Breast Cancer Management

Colocalization of Cancer-Associated Biomarkers on Single Extracellular Vesicles for Early Detection of Cancer

Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer

In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions

In Situ Labeling of the Aqueous Compartment of Extracellular Vesicles with Luminescent Gold Nanoclusters

Exploring Breast Cancer-Related Biochemical Changes in Circulating Extracellular Vesicles Using Raman Spectroscopy

Unveiling Invisible Extracellular Vesicles: Cutting-Edge Technologies for Their in Vivo Visualization

All-in-One Nanowire Assay System for Capture and Analysis of Extracellular Vesicles from an ex Vivo Brain Tumor Model